These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8837382)

  • 1. Liposomal amikacin for treatment of M. avium infections in clinically relevant experimental settings.
    Ehlers S; Bucke W; Leitzke S; Fortmann L; Smith D; Hänsch H; Hahn H; Bancroff G; Müller R
    Zentralbl Bakteriol; 1996 Jul; 284(2-3):218-31. PubMed ID: 8837382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice.
    Düzgüneş N; Perumal VK; Kesavalu L; Goldstein JA; Debs RJ; Gangadharam PR
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1404-11. PubMed ID: 3196002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for and efficacy of prolonged-interval treatment using liposome-encapsulated amikacin in experimental Mycobacterium avium infection.
    Leitzke S; Bucke W; Borner K; Müller R; Hahn H; Ehlers S
    Antimicrob Agents Chemother; 1998 Feb; 42(2):459-61. PubMed ID: 9527808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal amikacin: improved treatment of Mycobacterium avium complex infection in the beige mouse model.
    Petersen EA; Grayson JB; Hersh EM; Dorr RT; Chiang SM; Oka M; Proffitt RT
    J Antimicrob Chemother; 1996 Nov; 38(5):819-28. PubMed ID: 8961051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides.
    Bermudez LE; Yau-Young AO; Lin JP; Cogger J; Young LS
    J Infect Dis; 1990 Jun; 161(6):1262-8. PubMed ID: 2345306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice.
    de Steenwinkel JE; van Vianen W; Ten Kate MT; Verbrugh HA; van Agtmael MA; Schiffelers RM; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2007 Nov; 60(5):1064-73. PubMed ID: 17846106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice.
    Cynamon MH; Swenson CE; Palmer GS; Ginsberg RS
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1179-83. PubMed ID: 2802546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different types of pulmonary granuloma necrosis in immunocompetent vs. TNFRp55-gene-deficient mice aerogenically infected with highly virulent Mycobacterium avium.
    Benini J; Ehlers EM; Ehlers S
    J Pathol; 1999 Sep; 189(1):127-37. PubMed ID: 10451499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads.
    Ehlers S; Kutsch S; Benini J; Cooper A; Hahn C; Gerdes J; Orme I; Martin C; Rietschel ET
    Immunology; 1999 Nov; 98(3):313-23. PubMed ID: 10583588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted delivery of amikacin into granuloma.
    Montes-Worboys A; Brown S; Regev D; Bellew BF; Mohammed KA; Faruqi I; Sharma P; Moudgil B; Antony VB
    Am J Respir Crit Care Med; 2010 Dec; 182(12):1546-53. PubMed ID: 20693382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige mice.
    Gangadharam PR; Perumal VK; Podapati NR; Kesavalu L; Iseman MD
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1400-3. PubMed ID: 2848444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome-encapsulated-gentamicin therapy of Mycobacterium avium complex infection in beige mice.
    Klemens SP; Cynamon MH; Swenson CE; Ginsberg RS
    Antimicrob Agents Chemother; 1990 Jun; 34(6):967-70. PubMed ID: 2393294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4+ T cells.
    Hänsch HC; Smith DA; Mielke ME; Hahn H; Bancroft GJ; Ehlers S
    Int Immunol; 1996 Aug; 8(8):1299-310. PubMed ID: 8918699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of immune effector mechanisms during infection with Mycobacterium avium in C57BL/6 mice.
    Haug M; Awuh JA; Steigedal M; Frengen Kojen J; Marstad A; Nordrum IS; Halaas Ø; Flo TH
    Immunology; 2013 Oct; 140(2):232-43. PubMed ID: 23746054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection.
    Peters K; Leitzke S; Diederichs JE; Borner K; Hahn H; Müller RH; Ehlers S
    J Antimicrob Chemother; 2000 Jan; 45(1):77-83. PubMed ID: 10629016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLC G-65 in combination with other agents in the therapy of Mycobacterium avium infection in beige mice.
    Cynamon MH; Klemens SP; Swenson CE
    J Antimicrob Chemother; 1992 Jun; 29(6):693-9. PubMed ID: 1387133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkey.
    Fielding RM; Moon-McDermott L; Lewis RO; Horner MJ
    Antimicrob Agents Chemother; 1999 Mar; 43(3):503-9. PubMed ID: 10049258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapeutic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice.
    Gangadharam PR; Ashtekar DA; Ghori N; Goldstein JA; Debs RJ; Düzgünes N
    J Antimicrob Chemother; 1991 Sep; 28(3):425-35. PubMed ID: 1960123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of a small unilamellar low-clearance liposomal amikacin formulation after extravascular administration.
    Fielding RM; Moon-McDermott L; Lewis RO
    J Drug Target; 1999; 6(6):415-26. PubMed ID: 10937287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series.
    Davis KK; Kao PN; Jacobs SS; Ruoss SJ
    BMC Pulm Med; 2007 Feb; 7():2. PubMed ID: 17319962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.